Tizanidine Tablet
Product Images NDC 76420-885

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 76420-885). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Figure 1)

Figure (Figure 1)
A line graph showing plasma tizanidine concentration (ng/mL) over 24 hours after dosing. It compares four conditions: 2 x 4 mg tizanidine tablets with food, tablets without food, capsules with food, and capsules without food. The concentration peaks around 1-2 hours post-dose and then declines over time for all conditions.*
FDA Label Image

Figure (Figure 2)

Figure (Figure 2)
A line graph showing improvement in Ashworth score over time (hours post-dose) comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The graph includes error bars and labels indicating the different dosage groups and placebo response across a 6-hour post-dose period.*
FDA Label Image

Figure (Figure 3)

Figure (Figure 3)
A line graph showing improvement in Ashworth Score over time at three study points: end of titration (week 3), end of maintenance (week 7), and endpoint (last observation carried forward). Two groups are compared: tizanidine (mean dose 28.8 mg) and placebo. The graph indicates better improvement for the tizanidine group, with mean values consistently below zero, while placebo groups remain near zero or slightly above over the study period.*
FDA Label Image

Figure (Label 2mg)

Figure (Label 2mg)
Multiple packaging labels for tizanidine tablets, USP 2 mg, from Enovachem Pharmaceuticals shown. Labels include various quantity pack sizes such as 10, 15, 30, 60, 90, 100, and 1000 tablets. Each label includes NDC numbers, barcodes, and distributor information for Viona Pharmaceuticals Inc. The tablets are described as white to off-white, uncoated, round, debossed, with storage instructions and cautionary statements.*
FDA Label Image

Figure (Label 4mg)

Figure (Label 4mg)
This image shows multiple labels for Tizanidine Tablets, USP 4 mg, relabeled or packaged by Enovachem Pharmaceuticals, located in Torrance, CA. Labels include varying quantities such as 10, 30, 100, 150, 300, and 1000 tablets per package. Distributed by Viona Pharmaceuticals Inc., the labels show NDC codes, lot numbers, expiration dates, barcodes, and unique serial numbers.*
FDA Label Image

Figure (Structure)

Figure (Structure)
Chemical structure of tizanidine hydrochloride, showing its molecular arrangement including a chlorinated aromatic ring and a thiazole moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.